{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T06:51:11Z","timestamp":1790923871038,"version":"4.1.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2000,10,1]],"date-time":"2000-10-01T00:00:00Z","timestamp":970358400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2000,10,1]],"date-time":"2000-10-01T00:00:00Z","timestamp":970358400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2000,10]]},"DOI":"10.1023\/a:1018758308979","type":"journal-article","created":{"date-parts":[[2003,2,19]],"date-time":"2003-02-19T15:54:14Z","timestamp":1045670054000},"page":"127-131","source":"Crossref","is-referenced-by-count":32,"title":["A Pharmacodynamic Study of Clopidogrel in Chronic Hemodialysis Patients"],"prefix":"10.1007","volume":"10","author":[{"given":"James S.","family":"Kaufman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Fiore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"Hasbargen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa Z.","family":"O'Connor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Perdriset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"271039_CR1","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1161\/01.ATV.12.4.430","volume":"12","author":"DC Mills","year":"1992","unstructured":"Mills DC, Puri R, Nu CJ, et al. Clopidogrel inhibits the binding of ADP analogues to the receptor mediating inhibition of platelet adenylate cyclase. Arterioscler Thromb 1992;12:430-436.","journal-title":"Arterioscler Thromb"},{"key":"271039_CR2","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0002-9343(96)80077-5","volume":"101","author":"AI. Schafer","year":"1996","unstructured":"Schafer AI. Antiplatelet therapy. Am J Med 1996; 101:199-209.","journal-title":"Am J Med"},{"key":"271039_CR3","doi-asserted-by":"crossref","first-page":":35","DOI":"10.1016\/0049-3848(79)90022-7","volume":"14","author":"JL David","year":"1993","unstructured":"David JL, Monfort F, Herion F, Raskinet R. Compared effects of three dose-levels of ticlopidine on platelet function in normal subjects. Thromb Res 1993;14:35-49.","journal-title":"Thromb Res"},{"key":"271039_CR4","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1527-3466.1993.tb00275.x","volume":"11","author":"JM Herbert","year":"1993","unstructured":"Herbert JM, Frehel D, Vallee E, et al. Clopidogrel, a novel antiplatelet and antithrombotic agent. Cardiovasc Drug Rev 1993;11:180-198.","journal-title":"Cardiovasc Drug Rev"},{"key":"271039_CR5","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/0049-3848(87)90398-7","volume":"48","author":"R Feliste","year":"1987","unstructured":"Feliste R, Delebassee D, Simon MF, et al. Broad spectrum anti-platelet activity of ticlopidine and PCR 4099 involves the suppression of the effects of released ADP. Thromb Res 1987;48:403-415.","journal-title":"Thromb Res"},{"key":"271039_CR6","first-page":"145","volume":"54","author":"RM Hardisty","year":"1990","unstructured":"Hardisty RM, Powling MJ, Nokes TJ. The action of ticlopidine on human platelets. Studies on aggregation, secretion, calcium mobilization and membrane glycoproteins. Thromb Haemost 1990;54:145-150.","journal-title":"Thromb Haemost"},{"key":"271039_CR7","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1182\/blood.V61.6.1081.1081","volume":"61","author":"G DiMinno","year":"1983","unstructured":"DiMinno G, Silver MJ, Murphy S. Monitoring the entry of new platelets into the circulation after ingestion of aspirin. Blood 1983;61:1081-1085.","journal-title":"Blood"},{"issue":"supplI","key":"271039_CR8","first-page":"I","volume":"96","author":"DJ Moliterno","year":"1997","unstructured":"Moliterno DJ, Topol EJ. Meta-analysis of platelet GP IIb\/IIIa antagonist, randomized clinical trials in ischemic heart disease: Consistent, durable salutary effects [abstract]. Circulation 1997;96(suppl I): I-475.","journal-title":"Circulation"},{"key":"271039_CR9","doi-asserted-by":"crossref","first-page":"745","DOI":"10.2165\/00003495-199754050-00006","volume":"54","author":"AJ Coukell","year":"1997","unstructured":"Coukell AJ, Markham A. Clopidogrel. Drugs 1997;54:745-750.","journal-title":"Drugs"},{"key":"271039_CR10","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1055\/s-0038-1650689","volume":"76","author":"B Boneu","year":"1996","unstructured":"Boneu B, Destelle G, on behalf of the Study Group. Platelet anti-aggregating activity and tolerance of clopidogrel in atherosclerotic patients. Thromb Haemost 1996;76:939-943.","journal-title":"Thromb Haemost"},{"key":"271039_CR11","doi-asserted-by":"crossref","first-page":"394","DOI":"10.7326\/0003-4819-129-5-199809010-00009","volume":"129","author":"PJ Sharis","year":"1998","unstructured":"Sharis PJ, Cannon CP, Loscalzo J. The antiplatelet effects of ticlopidine and clopidogrel. Ann Intern Med 1998;129:394-405.","journal-title":"Ann Intern Med"},{"key":"271039_CR12","doi-asserted-by":"crossref","first-page":"856","DOI":"10.2165\/00003495-199549060-00002","volume":"49","author":"M Verstraete","year":"1995","unstructured":"Verstraete M, Zoldhelyi P. Novel antithrombotic drugs in development. Drugs 1995;49:856-884.","journal-title":"Drugs"},{"key":"271039_CR13","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2165\/00003088-199426050-00003","volume":"26","author":"JP. Desager","year":"1994","unstructured":"Desager JP. Clinical pharmacokinetics of ticlopidine. Clin Pharmacokinet 1994;26:347-355.","journal-title":"Clin Pharmacokinet"},{"key":"271039_CR14","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/978-1-4613-8306-2_3","volume-title":"Ticlopidine, Platelets, and Vascular Diseases","author":"P. Teitelbaum","year":"1993","unstructured":"Teitelbaum P. Pharmodynamics and pharmacokinetics of ticlopidine. In: Hass WK, Easton JD, eds. Ticlopidine, Platelets, and Vascular Diseases. New York: Springer-Verlag, 1993:27-40."},{"key":"271039_CR15","first-page":"1465","volume-title":"Cardiovascular Drug Therapy","author":"JW. Harbison","year":"1996","unstructured":"Harbison JW. Ticlopidine hydrochloride. In: Messerli FH, ed. Cardiovascular Drug Therapy. Philadelphia: WB Saunders, 1996: 1465-1473."},{"key":"271039_CR16","doi-asserted-by":"crossref","first-page":"222","DOI":"10.2165\/00003495-198734020-00003","volume":"34","author":"E Saltiel","year":"1987","unstructured":"Saltiel E, Ward A. Ticlopidine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in platelet-dependent disease states. Drugs 1987;34:222-262.","journal-title":"Drugs"},{"key":"271039_CR17","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1161\/01.CIR.98.22.2461","volume":"98","author":"LA Harker","year":"1998","unstructured":"Harker LA, Marzec UM, Kelly AB, et al. Clopidogrel inhibition of stent, graft, and vascular thrombogenesis with antithrombotic enhancement by aspirin in non-human primates. Circulation 1998;98:2461-2469.","journal-title":"Circulation"},{"key":"271039_CR18","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1056\/NEJM199812033392303","volume":"339","author":"MB Leon","year":"1998","unstructured":"Leon MB, Baim DS, Popma JJ, et al. A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. N Engl J Med 1998; 339:1665-1671.","journal-title":"N Engl J Med"},{"key":"271039_CR19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1681\/ASN.V311","volume":"3","author":"P Fan","year":"1992","unstructured":"Fan P, Schwab S. Vascular access: Concepts for the 1990's. J Am Soc Nephrol 1992;3:1-11.","journal-title":"J Am Soc Nephrol"},{"key":"271039_CR20","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0272-6386(12)80391-X","volume":"21","author":"D. Windus","year":"1993","unstructured":"Windus D. Permanent vascular access: A nephrologist's view. Am J Kidney Dis 1993;21:457-471.","journal-title":"Am J Kidney Dis"},{"key":"271039_CR21","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1161\/01.CIR.80.6.1726","volume":"80","author":"S Swedberg","year":"1989","unstructured":"Swedberg S, Brown B, Sigley R, Wright T, Gordon D, Nicholls S. Intimal fibromuscular hyperplasia at the venous anastomosis of PTFE grafts in hemodialysis patients. Circulation 1989;80:1726-1736.","journal-title":"Circulation"},{"key":"271039_CR22","first-page":"1287","volume":"10","author":"C. Hehrlein","year":"1995","unstructured":"Hehrlein C. How do AV fistulae lose function? The roles of haemodynamics, vascular remodelling, and intimal hyperplasia. Nephrol Dial Transplant 1995;10:1287-1290.","journal-title":"Nephrol Dial Transplant"},{"key":"271039_CR23","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/0049-3848(91)90377-9","volume":"62","author":"D Domoto","year":"1991","unstructured":"Domoto D, Bauman J, Joist J. Combined aspirin and sulfinpyrazone in the prevention of recurrent hemodialysis vascular access thrombosis. Thromb Res 1991;62:737-743.","journal-title":"Thromb Res"},{"key":"271039_CR24","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1038\/ki.1994.192","volume":"45","author":"R Sreedhara","year":"1994","unstructured":"Sreedhara R, Himmelfarb J, Lazarus J, Hakim R. Antiplatelet therapy in expanded polytetrafluoroethylene (ePTFE) graft thrombosis: Results of a prospective, randomized double-blind study. Kidney Int 1994;45:1477-1483.","journal-title":"Kidney Int"},{"key":"271039_CR25","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2165\/00044011-199816040-00006","volume":"4","author":"G Deray","year":"1998","unstructured":"Deray G, Bagnis C, Brouard R, et al. Clopidogrel activities in patients with renal function impairment. Clin Drug Invest 1998;4:319-328.","journal-title":"Clin Drug Invest"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1018758308979.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1018758308979\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1018758308979.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T07:08:25Z","timestamp":1754636905000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1018758308979"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,10]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2000,10]]}},"alternative-id":["271039"],"URL":"https:\/\/doi.org\/10.1023\/a:1018758308979","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"value":"0929-5305","type":"print"},{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,10]]}}}